Here, we present evidence that EGCG inhibits the invasive potential of melanoma cells through transition of mesenchymal state to epithelial state in melanoma cells and that EGCG do so through a process that involves the reduction of COX-2 expression and lowering the levels of PGE2 and PGE2 receptors in melanoma cells. This evidence concerns the gene PTGS2 and melanoma.